Panel Discussion: India Pharma 2030 Can North India become the next global manufacturing powerhouse
Chandigarh Pharma Summit 2026 | 16th July 2026
Author
Mr Shivaji Chakraborty, Head – Packaging Development, Fresenius Kabi Oncology
Chandigarh Pharma Summit 2026 | 16th July 2026
Mr Abhinav Vikash, Head Engineering, Sun Pharmaceutical Industries
Chandigarh Pharma Summit 2026 | 16th July 2026
Panel Discussion: From generic success to innovation leadership What’s next for Indian Pharma
Chandigarh Pharma Summit 2026 | 16th July 2026
Mr Krutik Prajapati, Manager (Techno Commercial), Vikram Thermo (India)
Chandigarh Pharma Summit 2026 | 16th July 2026
Panel Discussion: Geopolitics, trade and trust The forces reshaping India Pharma Inc
Chandigarh Pharma Summit 2026 | 16th July 2026
Dr Sanjit Singh Lamba, Managing Partner, Trillyum Consulting
Chandigarh Pharma Summit 2026 | 16th July 2026
Cipla receives US FDA approval for Generic Advair Diskus
Cipla and its wholly owned subsidiary Cipla USA announced that it has received US Food and Drug Administration (FDA) approval for…